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Abstract
Background: Kawasaki disease is an acute, systemic vasculitis that affects the coronary arteries. However, the
relationship between myocardial fibrosis and Kawasaki disease has been completely unknown until now. We aimed to
provide quantitative information about myocardial fibrosis using cardiac integrated backscatter in Han race Kawasaki
disease patients.
Methods: Ninety Kawasaki disease patients and 90 healthy control subjects were recruited. Based on Kawasaki disease
status, the patients were categorized into 3 groups: acute, subacute, and convalescence phase. Based on coronary
artery status, the Kawasaki disease patients were categorized into 3 groups: without coronary artery lesions, with
coronary artery dilation, and with coronary artery aneurysms. All subjects underwent two-dimensional and Doppler
examinations to measure clinical echocardiographic parameters. Myocardial fibrosis was detected with calibrated
integrated backscatter imaging.
Results: Left ventricle systolic functions were normal in both the Kawasaki disease and control participants. The
myocardial calibrated integrated backscatter values of the left ventricles of the acute (p < 0.001), subacute (p < 0.001)
and convalescence phase (p < 0.001) Kawasaki disease patients were significantly greater than those of the healthy
controls. The left ventricle myocardial calibrated integrated backscatter values were significantly smaller in the Kawasaki
disease patients without coronary artery lesions than in the Kawasaki disease patients with coronary artery dilations
and coronary artery aneurysms in different phases. The left ventricle myocardial calibrated integrated backscatter results
were positively correlated with coronary artery status in the acute (r = 0.331, p < 0.001), subacute (r = 0.456, p < 0.001)
and convalescence phases (r = 0.407, p < 0.001) of Kawasaki disease.
Conclusion: Our findings may suggest that myocardial fibrosis occurs during early episodes of Kawasaki disease given
uncertainties that exist regarding correlations of calibrated integrated backscatter and myocardial fibrosis.
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Background
Kawasaki disease is an acute, self-limited, systemic vascu-
litis of unknown etiology that most notably affects the cor-
onary arteries [1]. The inflammatory process produces
peculiar vascular damage that includes coronary artery le-
sions and myocarditis [2]. Myocardial ischemia remains
an important concern, and regular evaluations of myocar-
dial function constitute an important part of the long-
term assessment of Kawasaki disease. Some authors have
reported that Kawasaki disease patients might be at risk for
developing ischemic cardiomyopathy due to abnormal myo-
cardial perfusion and reduced coronary flow reserve, includ-
ing patients who do not have coronary artery lesions [3–6].
Myocardial fibrosis in Kawasaki disease is still contro-
versial due to limited evidence. Myocardial fibrosis has
been documented in one patient via endomyocardial bi-
opsy as long as 11 years after the occurrence of acute
Kawasaki disease [7]. Lin et al. [8] found alterations in
extracellular matrix biomarkers in Kawasaki disease pa-
tients that were suggestive of enhanced collagen syn-
thesis and myocardial fibrosis in adolescents and young
adults late after the onset of Kawasaki disease. With
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blood measurement and tissue autopsy, Numano et al.
[9] found Galectin-3 could be a marker of myocardial
and vascular fibrosis in Kawasaki disease patients with
giant aneurysms. However, myocardial fibrosis was not
observed in myocardial tissue of Kawasaki disease with
normal coronary arteries [9].
However, myocardial biopsies are not practical for
myocardial fibrosis diagnoses in children. Furthermore,
the cardiac origin of circulating markers of collagen syn-
thesis is difficult to ascertain, and the levels of these
markers vary with age and growth, which may confound
the interpretation of the results of pediatric studies [10].
In contrast, noninvasive assessment of tissue fibrosis via
echocardiographically derived calibrated integrated back-
scatter has been used in both adults and children [11–13].
Moreover, calibrated integrated backscatter has been used
to quantitatively evaluate the echogenicity of the heart in
Kawasaki disease [13–16]. Recently, it is questionable
about the role of calibrated integrated backscatter as a
non-invasive index of fibrosis in clinical studies of pa-
tients without extensive fibrosis such as coronary artery
disease [17].
However, data derived from small samples, specificities
of the equipment used, different measurements of cali-
brated integrated backscatter and variability due to race
may have important effects on calibrated integrated back-
scatter data. Therefore, the reproducibility of calibrated
integrated backscatter measurements needs to be exam-
ined in large samples to confirm the reported results.
Moreover, whether calibrated integrated backscatter is as-
sociated with lesser degrees of fibrosis is unknown. In the
present study, we postulated that calibrated integrated
backscatter might provide quantitative information about
myocardial fibrosis in early episode of Kawasaki disease.
Furthermore, we explored the associations of fibrosis with
myocardial calibrated integrated backscatter results and




Ninety Kawasaki disease patients and 90 healthy controls
were prospectively recruited from a group of cardiac in-
patients and from the clinic (from January 2014 to January
2015). The healthy controls underwent echocardiography
examinations for soft heart murmurs in the clinic, and
heart disease was completely ruled out for these subjects.
The following data were collected from the case notes:
demographic data, age at diagnosis, development of cor-
onary artery complications, and current cardiac medica-
tions. Based on Kawasaki disease status, the patients were
categorized into the following 3 groups: group 1, acute
phase (5-10th day); group 2, subacute phase (11-21th day),
and group 3, convalescence phase (28th day – 3rd month).
Group 4 was composed of the healthy controls. Based on
coronary artery status, the Kawasaki disease patients were
categorized into the following 3 groups: group A, no cor-
onary artery lesions; group B, coronary artery dilation; and
group C, coronary artery aneurysms. Group D was com-
posed of the healthy controls. The echocardiographic data
were compared between the patients and the healthy age-
matched control subjects.
Diagnoses of Kawasaki disease were made based on
standard clinical criteria [18]. Coronary artery dilations
and coronary artery aneurysms were documented by
echocardiography according to the criteria set by the
Japanese Ministry of Health [19].
Ethics statement
This study was approved by the Institutional Review
Board of Shanghai Children’s Hospital/Shanghai Jiaotong
University, and informed written consent was obtained
from all subjects and parents on behalf of minors.
Clinical echocardiography
Echocardiography was performed by a single experienced
pediatric cardiologist. All the Kawasaki disease patients
and controls underwent transthoracic two-dimensional
and Doppler examinations using a Philips IE-33 ultra-
sound machine. The probes used were S4 and S8. The
children were prepared for echocardiography via the ad-
ministration of a sedative (10 % chloral hydrate 50 mg/kg
administered orally) as usually required in clinical practice
in China.
Calibrated integrated backscatter assessment
The calibrated integrated backscatter was assessed using
QLAB software. The calibrated integrated backscatter
measurements were performed as previously reported
[11]. Integrated backscatter curves were acquired in the
parasternal short-axis view by locating 3 × 3-mm sample
volumes in the mid-basal septum, mid-posterior wall,
and mid-pericardium in end diastole. The calibrated in-
tegrated backscatter measurements were performed at a
fixed point in the cardiac cycle (i.e., the peak of the QRS
complex) and are expressed in decibels. The pericardial
integrated backscatter was used as the baseline. The left
ventricular calibrated integrated backscatter was calcu-
lated by subtracting the average pericardial integrated
backscatter intensity from the average myocardial inte-
grated backscatter intensity of the septum and posterior
wall (Fig. 1). The sample volumes were tracked manually
to maintain the same region throughout the heart cycle.
Reproducibility
Off-line analyses of the calibrated integrated backscatter
data were performed by two blinded independent ob-
servers. Interobserver variability was tested in 10 cases of
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Kawasaki disease and 10 control cases. The same samples
were re-evaluated after a 20-day period by one of the two
observers to assess intraobserver variability.
Statistical analysis
All clinical echocardiographic data and integrated back-
scatter profiles were averaged over three consecutive
cardiac cycles. The data are presented as the means ±
the SDs unless otherwise stated. The demographic and
echocardiographic parameters were compared between
the patients with different Kawasaki disease statuses and
the controls using unpaired Student's t tests. The cali-
brated integrated backscatter values of the patients in
the different phases of Kawasaki disease and the healthy
controls were compared with one-way ANOVA tests.
Tukey’s post-hoc test was used whenever statistically sig-
nificant differences were observed. Spearman correlation
analysis was used to determine the association between
the myocardial calibrated integrated backscatter results
and the coronary artery statuses of the Kawasaki disease
patients. P values <0.05 were considered statistically sig-




All subjects were of Han nationality. The 90 (58 males,
64.4 %) Kawasaki disease patients were studied at 18.40 ±
10.07 months, and the 90 (55 males, 61.1 %) healthy con-
trols were studied at 17.93 ± 11.59 months (p = 0.773).
Neither gender (64.4 % vs. 61.1 %, p = 0.646) nor body
weight (11.72 ± 3.03 kg vs. 11.41 ± 3.48 kg, p = 0.525)
differed significantly between the Kawasaki disease and
control cohorts.
The gender distribution was different (47 males, 62.7 %
vs. 10 males, 83.3 % vs. 1 male, 33.3 % vs. 55 males,
61.1 %, p < 0.001) in subgroup A, B, C and D. Neither age
(17.87 ± 9.74 vs. 21.92 ± 11.83 vs. 17.67 ± 12.22 vs. 17.93 ±
11.59 months, p = 0.675) nor body weight (11.63 ± 2.91 kg
vs. 12.28 ± 3.70 kg vs. 11.57 ± 4.05 kg vs. 11.41 ± 3.48 kg,
p = 0.846) differed significantly in subgroup A, B, C and D.
All patients were treated with 2 g/kg immunoglobulin
intravenously in a single dose and 50–80 mg/kg aspirin
during the acute phase of the illness (5-10th day)
followed by 3–5 mg/kg per day for 6–8 weeks after the
resolution of the acute illness. Aspirin was continued
chronically at the same dose in children in whom coron-
ary abnormalities persisted.
Clinical echocardiographic parameters
Table 1 summarizes the clinical echocardiographic pa-
rameters in patients in the different phases of Kawasaki
disease and the control subjects. Left ventricle systolic
and diastolic functions were normal, and no significant
differences in either parameter were observed between
the Kawasaki disease patients and controls. Left ventricle
masses did not differ across all of the subjects. Among
the Kawasaki disease cohorts, 75 (83.3 %) cases were
without coronary artery lesions, 12 (13.3 %) cases exhib-
ited coronary artery dilation, and 3 (3.3 %) cases had
coronary artery aneurysms.
Myocardial calibrated integrated backscatter
The myocardial calibrated integrated backscatter values
for the left ventricle were significantly smaller in the
Fig. 1 Calibrated integrated backscatter (cIB) of the left ventricle (LV) assessed with QLAB software
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healthy control subjects than the Kawasaki disease patients
in the acute (−22.57 ± 5.43 vs. -17.60 ± 4.78, p < 0.001), sub-
acute (−22.57 ± 5.43 vs. -18.31 ± 4.27, p < 0.001) and conva-
lescence (−22.57 ± 5.43 vs. -18.71 ± 4.30, p < 0.001) phases
(Fig. 2). Furthermore, the myocardial calibrated integrated
backscatter values for the left ventricle were significantly
smaller in the healthy controls than in the Kawasaki dis-
ease patients without coronary artery lesions in the acute
(−22.57 ± 5.43 vs. -18.93 ± 3.95, p < 0.001), subacute
(−22.57 ± 5.43 vs. -19.51 ± 3.50, p < 0.001) and convales-
cence (−22.57 ± 5.43 vs. -19.98 ± 3.36, p < 0.001) phases
(Fig. 3). Finally, the myocardial calibrated integrated back-
scatter values for the left ventricle were significantly greater
in the Kawasaki disease patients with coronary artery aneu-
rysms and coronary artery dilation compared with the
Kawasaki disease patients without coronary artery lesions
in the acute (−7.77 ± 1.71 vs. -11.71 ± 1.85 vs. -18.93 ± 3.95),
subacute (−9.27 ± 0.85 vs. -13.08 ± 1.85 vs. -19.51 ± 3.5)
and convalescence phase (−9.23 ± 0.31 vs. -13.13 ± 2.02
vs. -19.98 ± 3.36) of illness (Fig. 4).
Table 1 Clinical echocardiographic parameters in KD and control
KD (acute) KD (subacute) KD (convalescence) Healthy control p
Left Ventricle
M-mode
LV EDD (mm) 33.6 ± 3.4 32.9 ± 3.6 33.3 ± 3.2 32.7 ± 2.5 0.56
LV ESD (mm) 17.1 ± 1.9 17.6 ± 1.4 16.9 ± 2.0 17.2 ± 1.7 0.32
IVSd (mm) 4.2 ± 0.5 4.3 ± 0.3 4.1 ± 0.4 4.1 ± 0.3 0.38
LV PWd (mm) 4.0 ± 0.4 4.1 ± 0.4 4.0 ± 0.5 4.1 ± 0.4 0.62
LV mass (g) 22.9 ± 0.4 22.3 ± 0.5 22.8 ± 0.5 23.0 ± 0.4 0.33
LV eject fraction (%) 68.3 ± 4.2 70.2 ± 6.1 69.5 ± 5.7 68.9 ± 5.5 0.14
Mitral inflow velocities
E (cm/s) 97.7 ± 10.2 105.4 ± 9.7 93.8 ± 13.5 98.7 ± 12.5 0.49
A (cm/s) 59.9 ± 12.5 57.5 ± 14.7 61.4 ± 13.2 62.3 ± 11.9 0.78
E/A ratio 1.6 ± 0.4 1.8 ± 0.4 1.5 ± 0.3 1.6 ± 0.4 0.65
Right ventricle
Tricuspid inflow velocities
E (cm/s) 71.0 ± 12.1 74.3 ± 10.5 69.8 ± 8.4 73.4 ± 15.1 0.84
A (cm/s) 50.0 ± 6.9 54.9 ± 9.8 53.8 ± 7.3 51.5 ± 5.3 0.33
E/A ratio 1.4 ± 0.3 1.4 ± 0.2 1.3 ± 0.2 1.4 ± 0.3 0.79
Abbreviations: KD Kawasaki disease, LV left ventricle, EDD end-diastolic dimension, ESD end-systolic dimension, IVSd interventricular septal thickness at diastole,
PWd posterior wall thickness at diastole
Fig. 2 Bar graph illustrating the calibrated integrated backscatter (cIB)
values of the left ventricles (LVs) in different phases of KD and
in healthy control subjects
Fig. 3 Bar graph illustrating the calibrated integrated backscatter
(cIB) values of the left ventricles (LVs) in different phases of KD
without coronary artery lesions (CALs) and in healthy
control subjects
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Correlates of calibrated integrated backscatter
Among the cohort of patients, the average myocardial
calibrated integrated backscatter values were positively
correlated with the Kawasaki disease patients’ coronary
artery statuses in the acute (r = 0.331, p < 0.001), sub-
acute (r = 0.456, p < 0.001) and convalescence (r = 0.407,
p < 0.001) phases (Fig. 5).
Reproducibility
The intra- and interobserver variability for the calibrated
integrated backscatter observations was 1.6 ± 1.5 (correl-
ation was 0.89 (95 % CI 0.75 to 0.95, p < 0.001)), and 1.7 ±
1.3 (correlation was 0.83 (95 % CI 0.70 to 0.89, p < 0.001)),
respectively.
Discussion
The present study demonstrated that increased myocar-
dial calibrated integrated backscatter values are suggest-
ive of myocardial fibrosis in Kawasaki disease patients
with and without coronary artery lesions despite similar
measures of left ventricle function between the Kawasaki
disease patients and healthy controls. Additionally, the
myocardial calibrated integrated backscatter results were
found to be positively associated with the Kawasaki dis-
ease patients’ coronary artery statuses.
Calibrated integrated backscatter is the intensity of an
ultrasound wave (scattering) within a particular frequency
range, as reflected by a tissue interface that is smaller than
the ultrasound wavelength (500 μm for a 3-MHz probe);
thus, the structures that contribute to the calibrated inte-
grated backscatter signal should be 100–125 μm or
smaller [20]. Myofibers, extracellular matrix collagen,
mitochondria, and small vessels are thought to be the
principal backscatterers in the myocardium [21]. With
the development of echocardiolographic technologies,
the relationship between calibrated integrated back-
scatter and myocardial fibrosis has been confirmed in
human disease [12, 22–24].
Kawasaki disease is a systemic vasculitis of unknown
origin that occurs primarily in children younger than
5 years. Many studies have focused on Kawasaki disease
with coronary artery lesions. However, few pathological
studies have examined the after-effects of Kawasaki dis-
ease on the myocardium based on endomyocardial biop-
sies [7, 25]. Recently, Yonesaka et al. [26] found that the
incidence of histopathological abnormalities, such as
degeneration, hypertrophy, and inflammatory cell infiltra-
tion, are quite high upon initial study and that inflamma-
tory cell infiltration, interstitial fibrosis, and disarray were
very noticeable upon follow-up biopsies in Kawasaki dis-
ease with giant coronary artery aneurysm. Furthermore, a
previous clinical study provided evidence of altered myo-
cardial extracellular matrix turnover with a possible pre-
disposition to increased interstitial fibrosis in adults with
Kawasaki disease histories [8]. Leonardi et al. [13] con-
firmed a significant increase in myocardial calibrated inte-
grated backscatter values in Kawasaki disease patients at
least 1 year after the acute episode. Nagata et al. [14] re-
ported that the integrated backscatter values of the coron-
ary artery wall, mitral valve, papillary muscle and
ascending aortic wall in Kawasaki disease patients in the
acute phase are significantly higher than those of control
subjects. Abe et al. [15] also reported that the integrated
backscatter values for the coronary artery wall are higher
in Kawasaki disease patients than in controls. More-
over, these authors also reported that the integrated
backscatter values for the coronary artery wall are
higher in pre-immunoglobulin therapy patients than
post-immunoglobulin therapy patients with Kawasaki
disease. However, Yu et al. [16] used a similar method
and reported no significant difference in the perivascu-
lar echo brightness of the coronary arteries between
Kawasaki disease patients.
The numbers of Kawasaki disease and control sub-
jects are much greater in the present study than those
in previous reports. However, the present study is the
first to report on the echogenicity of the left ventricle
myocardium in Han race Kawasaki disease patients
based on the calibrated integrated backscatter method
with QLAB software. Our results demonstrated greater
Fig. 4 Histogram illustrating the calibrated integrated backscatter (cIB) values for the left ventricles (LV) in the different KD phase cohorts with
and without coronary artery lesions (CALs). CAD: coronary artery dilation; CAA: coronary artery aneurysm
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myocardial calibrated integrated backscatter values in
the Kawasaki disease patients in the acute, subacute
and convalescence phases compared with controls.
Moreover, greater myocardial calibrated integrated
backscatter values observed in the Kawasaki disease pa-
tients with coronary artery lesions compared with the
Kawasaki disease patients without coronary artery le-
sions. Finally, we revealed that the calibrated integrated
backscatter values were positively correlated with the
Kawasaki disease patients’ coronary artery statuses.
Calibrated integrated backscatter data have been cor-
related with myocardial collagen distribution and con-
tent and are thought to be a marker of fibrosis [12, 13].
Myocarditis is uniformly present during the acute phase
of Kawasaki disease and resolves early in its clinical
course. An increase in collagen content is a common re-
sponse to myocarditis and might have been the cause of
the elevated calibrated integrated backscatter values ob-
served in our patients. Thus, histological alterations,
such as edema and cell infiltration associated with in-
flammation of tissues, alter the acoustic properties of tis-
sues [27]. The results of the present study suggest that
edematous changes and cell infiltration in the ventricular
myocardium will develop in the acute phase of Kawasaki
disease and persist for a long time. Our data indicate
that myocardial fibrosis may occur during early episodes
of Kawasaki disease and that calibrated integrated back-
scatter is a simple, easy, and noninvasive echocardio-
graphic method for the evaluation of myocardial
fibrosis in Kawasaki disease.
Several limitations to this study warrant discussion.
First, the subjects’ thoracic thicknesses may have af-
fected the calibrated integrated backscatter values, but
we did not consider this issue. Second, the modality of
cardiac magnetic resonance imaging (MRI) T1 mapping,
which is ideal for assessments of diffuse myocardial fi-
brosis, was not available to us due to economic reasons
and the requirement for deeper sedation. Notably, how-
ever, conditions other than fibrosis may also influence
extracellular volume measurements acquired via T1
mapping [28]. Third, we did not examine circulating
markers of collagen synthesis in the present study. The
cardiac origins of these collagen synthesis biomarkers
are difficult to ascertain. More importantly, the levels of
these markers vary with age and growth, which may
confound the interpretation of the results of pediatric
studies [10]. Fourth, lack of histological evidence, we
could not evaluate the extensive myocardial fibrosis in
Kawasaki disease. So, calibrated integrated backscatter
maybe reflect not only fibrosis but also myocardium
inflammation especially in acute phase. Finally, we did
not examine the LV strains or strain rates with tissue
Doppler or two-dimensional echocardiography in the
present study.
Conclusion
Our findings suggest that calibrated integrated backscat-
ter values are different in Kawasaki disease and may sug-
gest myocardial fibrosis occurs during early episodes of
Kawasaki disease given uncertainties that exist regarding
correlations of calibrated integrated backscatter and
myocardial fibrosis. Furthermore, calibrated integrated
backscatter value is related to the status of the coronary
artery in Kawasaki disease. Our findings reinforce the
Fig. 5 Scatter plots illustrating the correlations between the myocardial
calibrated integrated backscatter values and coronary artery statuses in
(a) the acute phase, (b) the subacute phase, and (c) the convalescence
phase. D: healthy controls; A: KD without CAL; B: KD with CAD; C: KD
with CAA
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concept that long-term follow-up is appropriate for all
Kawasaki disease patients independent of the presence
of coronary artery lesions. Whether anti-fibrotic strat-
egies, such as aldosterone antagonism, may alter myo-
cardial acoustic properties and improve myocardial
fibrosis progression in Kawasaki disease is a topic for
further studies.
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